NVCR News and Press, NovoCure Limited From 09/04/20

Novocure (NASDAQ: NVCR) announced today that William Doyle, the company’s Executive Chairman, and Dr. Uri Weinberg, the company’s Chief Science Officer, will participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 9, 2020. Mr. Doyle and Dr. Weinberg will t...

The stock market has a way of surprising and our overbought indicator suggests investors banking on uninterrupted gains could be disappointed. Weekly, we track how many of the 1,500 widely-traded stocks in our marketplace universe are trading 5% or higher above their 200-day moving average. ...

Wilco Groenhuysen appointed to an expanded Chief Operating Officer role Ashley Cordova promoted to Chief Financial Officer Frank Leonard promoted to Chief Development Officer Novocure (NASDAQ:NVCR) today announced an expansion of its Executive Leadership Team, effective Sept....

Image source: The Motley Fool. NovoCure   (NASDAQ: NVCR) Q2 2020 Earnings Call Jul 30, 2020 , 8:00 a.m. ET Operator Continue reading

NovoCure Limited (NVCR) Q2 2020 Results Conference Call July 30, 2020 08:00 AM ET Company Participants Ashley Cordova - Senior Vice President of Finance & Investor Relations Bill Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Wilco Groenhuysen - Chief Fi...

The following slide deck was published by NovoCure Limited in conjunction with their 2020 Q2 earnings Read more ...

Quarterly net revenues of $115.9 million, representing 34 percent growth versus the second quarter 2019 and 14 percent growth versus the first quarter 2020 Financial strength allows for continued investments in clinical and product innovation Novocure (NASDAQ: NVCR) today reported...

Novocure (NASDAQ:NVCR) announced today the recipients of the AACR-Novocure Grants for Tumor Treating Fields Research program. The program represents a joint effort between Novocure and the American Association for Cancer Research (AACR) to promote and support innovative research on Tumor Trea...

XBiotech makes a crucial breakthrough in True Human antibodies Development XBiotech Inc. (XBIT) reported that it has made an important breakthrough in the development of True Human antibodies, novel inflammation countering mechanism. This new type of antibody seeks to replace previous-gene...

In this episode of Industry Focus: Wildcard , Jason Moser chats with Motley Fool analyst Brian Feroldi about three promising healthcare stocks that he personally bought. Discover their innovative products, which facilitate easy and quick diagnosis of peripheral artery disease -- plus, a "medi...